熊果酸/油醇酸的生物利用率,具有治疗慢性疾病和癌症的潜力。

IF 2.1 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Advances in Clinical and Experimental Medicine Pub Date : 2024-11-28 DOI:10.17219/acem/194013
Vasile Staicu, Justinian-Andrei Tomescu, Ioan Calinescu
{"title":"熊果酸/油醇酸的生物利用率,具有治疗慢性疾病和癌症的潜力。","authors":"Vasile Staicu, Justinian-Andrei Tomescu, Ioan Calinescu","doi":"10.17219/acem/194013","DOIUrl":null,"url":null,"abstract":"<p><p>This study focused on describing the bioavailability of ursolic/oleanolic acids (UA/OA) and the methods to increase it, so that these 2 bioactive compounds can have therapeutic and preventive effects in chronic diseases and cancer. Ursolic/oleanolic acids are natural compounds that have been known since the 19th century. They are very widespread and offer special benefits for human health - especially that their high absorbability makes them suitable for use in therapeutic and preventive treatment. One of the important aspects of their bioavailability is related to their interaction with other bioactive compounds or drugs. In chronic diseases and cancer, UA/OA may affect the absorption of other nutrients and interact with bioactive compounds. By increasing the bioavailability of UA/OA with various technical processes, especially using nanocarriers and nanoparticles, these compounds can affect collagen production, contributing to maintaining skin elasticity and preventing the appearance of wrinkles. Today, UA/OA are frequently used to treat many conditions, ranging from chronic to metabolic.</p>","PeriodicalId":7306,"journal":{"name":"Advances in Clinical and Experimental Medicine","volume":" ","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Bioavailability of ursolic/oleanolic acid, with therapeutic potential in chronic diseases and cancer.\",\"authors\":\"Vasile Staicu, Justinian-Andrei Tomescu, Ioan Calinescu\",\"doi\":\"10.17219/acem/194013\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This study focused on describing the bioavailability of ursolic/oleanolic acids (UA/OA) and the methods to increase it, so that these 2 bioactive compounds can have therapeutic and preventive effects in chronic diseases and cancer. Ursolic/oleanolic acids are natural compounds that have been known since the 19th century. They are very widespread and offer special benefits for human health - especially that their high absorbability makes them suitable for use in therapeutic and preventive treatment. One of the important aspects of their bioavailability is related to their interaction with other bioactive compounds or drugs. In chronic diseases and cancer, UA/OA may affect the absorption of other nutrients and interact with bioactive compounds. By increasing the bioavailability of UA/OA with various technical processes, especially using nanocarriers and nanoparticles, these compounds can affect collagen production, contributing to maintaining skin elasticity and preventing the appearance of wrinkles. Today, UA/OA are frequently used to treat many conditions, ranging from chronic to metabolic.</p>\",\"PeriodicalId\":7306,\"journal\":{\"name\":\"Advances in Clinical and Experimental Medicine\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2024-11-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in Clinical and Experimental Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.17219/acem/194013\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Clinical and Experimental Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.17219/acem/194013","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

这项研究的重点是描述熊果酸/油菜醇酸(UA/OA)的生物利用率以及提高其生物利用率的方法,从而使这两种生物活性化合物对慢性疾病和癌症具有治疗和预防作用。熊果酸/油菜醇酸是一种天然化合物,早在 19 世纪就已为人所知。它们非常普遍,对人体健康有特殊的益处,尤其是它们的高吸收性使其适合用于治疗和预防。它们的生物利用率的一个重要方面与它们与其他生物活性化合物或药物的相互作用有关。在慢性疾病和癌症中,UA/OA 可能会影响其他营养素的吸收,并与生物活性化合物相互作用。通过各种技术工艺,特别是使用纳米载体和纳米颗粒来提高 UA/OA 的生物利用率,这些化合物可以影响胶原蛋白的生成,有助于保持皮肤弹性和防止皱纹的出现。如今,UA/OA 常用于治疗多种疾病,包括慢性病和代谢性疾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Bioavailability of ursolic/oleanolic acid, with therapeutic potential in chronic diseases and cancer.

This study focused on describing the bioavailability of ursolic/oleanolic acids (UA/OA) and the methods to increase it, so that these 2 bioactive compounds can have therapeutic and preventive effects in chronic diseases and cancer. Ursolic/oleanolic acids are natural compounds that have been known since the 19th century. They are very widespread and offer special benefits for human health - especially that their high absorbability makes them suitable for use in therapeutic and preventive treatment. One of the important aspects of their bioavailability is related to their interaction with other bioactive compounds or drugs. In chronic diseases and cancer, UA/OA may affect the absorption of other nutrients and interact with bioactive compounds. By increasing the bioavailability of UA/OA with various technical processes, especially using nanocarriers and nanoparticles, these compounds can affect collagen production, contributing to maintaining skin elasticity and preventing the appearance of wrinkles. Today, UA/OA are frequently used to treat many conditions, ranging from chronic to metabolic.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Advances in Clinical and Experimental Medicine
Advances in Clinical and Experimental Medicine MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
3.70
自引率
4.80%
发文量
153
审稿时长
6-12 weeks
期刊介绍: Advances in Clinical and Experimental Medicine has been published by the Wroclaw Medical University since 1992. Establishing the medical journal was the idea of Prof. Bogumił Halawa, Chair of the Department of Cardiology, and was fully supported by the Rector of Wroclaw Medical University, Prof. Zbigniew Knapik. Prof. Halawa was also the first editor-in-chief, between 1992-1997. The journal, then entitled "Postępy Medycyny Klinicznej i Doświadczalnej", appeared quarterly. Prof. Leszek Paradowski was editor-in-chief from 1997-1999. In 1998 he initiated alterations in the profile and cover design of the journal which were accepted by the Editorial Board. The title was changed to Advances in Clinical and Experimental Medicine. Articles in English were welcomed. A number of outstanding representatives of medical science from Poland and abroad were invited to participate in the newly established International Editorial Staff. Prof. Antonina Harłozińska-Szmyrka was editor-in-chief in years 2000-2005, in years 2006-2007 once again prof. Leszek Paradowski and prof. Maria Podolak-Dawidziak was editor-in-chief in years 2008-2016. Since 2017 the editor-in chief is prof. Maciej Bagłaj. Since July 2005, original papers have been published only in English. Case reports are no longer accepted. The manuscripts are reviewed by two independent reviewers and a statistical reviewer, and English texts are proofread by a native speaker. The journal has been indexed in several databases: Scopus, Ulrich’sTM International Periodicals Directory, Index Copernicus and since 2007 in Thomson Reuters databases: Science Citation Index Expanded i Journal Citation Reports/Science Edition. In 2010 the journal obtained Impact Factor which is now 1.179 pts. Articles published in the journal are worth 15 points among Polish journals according to the Polish Committee for Scientific Research and 169.43 points according to the Index Copernicus. Since November 7, 2012, Advances in Clinical and Experimental Medicine has been indexed and included in National Library of Medicine’s MEDLINE database. English abstracts printed in the journal are included and searchable using PubMed http://www.ncbi.nlm.nih.gov/pubmed.
期刊最新文献
Bioavailability of ursolic/oleanolic acid, with therapeutic potential in chronic diseases and cancer. Development and validation of the antibody-dependent cellular phagocytosis-based signature: A prognostic risk model of gastric cancer. Laboratory synthesis and preparation of thermo-responsive polymeric micelle and hydrogel for resveratrol delivery and release. Otolaryngological manifestations in patients with obstructive sleep apnea and continuous positive airway pressure users: A systematic review. Prognostic value of inflammation-related model in hepatitis B acute-on-chronic liver failure.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1